Immediate Impact

6 by Nobel laureates 16 from Science/Nature 86 standout
Sub-graph 1 of 22

Citing Papers

Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
2022 Standout
Muco-Obstructive Lung Diseases
2019 Standout
97 intermediate papers

Works of Carol Parr being referenced

Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy.
1994
Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy.
1994

Author Peers

Author Last Decade Papers Cites
Carol Parr 59 349 25 185 69 4 428
T. K. Harden 32 333 30 228 79 7 442
Sabine Meis 20 372 13 187 52 7 502
M B Zimmerman 93 248 16 249 35 8 472
Heiko Ullmann 16 325 11 184 75 8 464
E. L. Gordon 22 211 33 150 41 8 439
Frédéric Marteau 15 350 24 180 50 7 451
Andrew Loesch 50 254 35 95 69 4 408
R. Kopp 17 271 15 99 52 6 374
Cinzia Montilli 24 261 17 104 45 10 511
Paula García-Huerta 15 205 16 248 38 6 485

All Works

Loading papers...

Rankless by CCL
2026